The article "Implementing Whole Genome Sequencing (WGS) in Clinical Practice: Advantages, Challenges, and Future Perspectives" by Petar Brek et al. discusses the integration of WGS into modern medicine, highlighting its role in advancing personalized medicine and improving diagnostic accuracy. WGS has revolutionized the field by enabling comprehensive analysis of the human genome, leading to better understanding and treatment of genetic diseases. The authors cover the history and evolution of WGS technologies, from Sanger sequencing to next-generation sequencing (NGS) and third-generation sequencing, emphasizing the significant improvements in cost, time, and accuracy. Key applications of WGS include rare disease genomics, oncogenomics, pharmacogenomics, neonatal screening, and infectious disease genomics. WGS is particularly useful in rare disease diagnosis, where it can identify variants in non-coding regions that are often missed by traditional methods. The technology also plays a crucial role in cancer genomics, allowing for early detection of somatic mutations and facilitating personalized cancer treatment. In pharmacogenomics, WGS helps in predicting drug responses and reducing adverse side effects by considering an individual's genetic makeup. The article also addresses the computational analysis of WGS data, including alignment, mapping, variant calling, and structural variant detection. These processes are essential for interpreting the vast amount of genetic information generated. Additionally, the authors discuss the importance of variant databases and population frequency analysis in classifying genetic variants, as well as the challenges and future prospects of WGS in clinical practice. Overall, WGS offers significant advantages in precision medicine, but it also faces challenges such as the interpretation of complex data and the need for interdisciplinary collaboration. The article concludes by emphasizing the ongoing advancements in WGS technology and its potential to transform healthcare, particularly in areas like prenatal and neonatal genetic testing, cancer genomics, and personalized medicine.The article "Implementing Whole Genome Sequencing (WGS) in Clinical Practice: Advantages, Challenges, and Future Perspectives" by Petar Brek et al. discusses the integration of WGS into modern medicine, highlighting its role in advancing personalized medicine and improving diagnostic accuracy. WGS has revolutionized the field by enabling comprehensive analysis of the human genome, leading to better understanding and treatment of genetic diseases. The authors cover the history and evolution of WGS technologies, from Sanger sequencing to next-generation sequencing (NGS) and third-generation sequencing, emphasizing the significant improvements in cost, time, and accuracy. Key applications of WGS include rare disease genomics, oncogenomics, pharmacogenomics, neonatal screening, and infectious disease genomics. WGS is particularly useful in rare disease diagnosis, where it can identify variants in non-coding regions that are often missed by traditional methods. The technology also plays a crucial role in cancer genomics, allowing for early detection of somatic mutations and facilitating personalized cancer treatment. In pharmacogenomics, WGS helps in predicting drug responses and reducing adverse side effects by considering an individual's genetic makeup. The article also addresses the computational analysis of WGS data, including alignment, mapping, variant calling, and structural variant detection. These processes are essential for interpreting the vast amount of genetic information generated. Additionally, the authors discuss the importance of variant databases and population frequency analysis in classifying genetic variants, as well as the challenges and future prospects of WGS in clinical practice. Overall, WGS offers significant advantages in precision medicine, but it also faces challenges such as the interpretation of complex data and the need for interdisciplinary collaboration. The article concludes by emphasizing the ongoing advancements in WGS technology and its potential to transform healthcare, particularly in areas like prenatal and neonatal genetic testing, cancer genomics, and personalized medicine.